Saad Gilani - Cyxone AB Director

CYXO Stock  SEK 0.03  0  11.11%   

Director

Mr. Saad Gilani was Director of Cyxone AB since October 2, 2015. He holds a degree in Electrical Engineering from Rutgers College of Engineering and MBA from Rutgers University in New Jersey, where he specialized in finance. He is CEO of Yorkville Advisors Global and member of company investment committee as well as Director of Temple Therapeutics BV. He was previously Manager at Healthcare Group. He also served at Keyence Corporationrationration. since 2015.
Age 44
Tenure 9 years
Professional MarksMBA
Phone46 7 08 88 21 72
Webhttps://www.cyxone.com

Cyxone AB Management Efficiency

The company has return on total asset (ROA) of (0.5861) % which means that it has lost $0.5861 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0658) %, meaning that it generated substantial loss on money invested by shareholders. Cyxone AB's management efficiency ratios could be used to measure how well Cyxone AB manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Found 6 records

DIRECTOR Age

Scott BoyerKlaria Pharma Holding
61
Anders MartinLofCantargia AB
48
Claus AnderssonCantargia AB
51
Patricia DelaiteCantargia AB
53
Karin LeanderssonCantargia AB
43
Thoas FioretosCantargia AB
53
Cyxone AB , a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis and multiple sclerosis and treatments for virally induced acute respiratory disorders. The company was founded in 2015 and is headquartered in Malm, Sweden. Cyxone AB is traded on Stockholm Stock Exchange in Sweden. Cyxone AB (CYXO) is traded on Stockholm Exchange in Sweden and employs 8 people.

Management Performance

Cyxone AB Leadership Team

Elected by the shareholders, the Cyxone AB's board of directors comprises two types of representatives: Cyxone AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cyxone. The board's role is to monitor Cyxone AB's management team and ensure that shareholders' interests are well served. Cyxone AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cyxone AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Malin Berthold, Project Manager
Theresa Olsen, Director
Bert Junno, Chairman of the Board
Ola Skanung, Interim Chief Executive Officer, Chief Financial Officer
Mikael Lindstam, Chief Operating Officer, Director
Erika Samuelsson, Chief Officer
Saad Gilani, Director
CarlMagnus Hogerkorp, COO CEO

Cyxone Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cyxone AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cyxone Stock Analysis

When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.